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Alternative promoter usage and alternative splicing enable diversification of the transcriptome. 
Here we demonstrate that the function of synaptic GTPase-Activating Protein (synGAP), a 
key synaptic protein, is determined by the combination of its amino-terminal sequence with its 
carboxy-terminal sequence. 5′ rapid amplification of cDnA ends and primer extension show 
that different n-terminal protein sequences arise through alternative promoter usage that are 
regulated by synaptic activity and postnatal age. Heterogeneity in C-terminal protein sequence 
arises through alternative splicing. overexpression of synGAP α1 versus α2 C-termini-containing 
proteins in hippocampal neurons has opposing effects on synaptic strength, decreasing 
and increasing miniature excitatory synaptic currents amplitude/frequency, respectively. 
The magnitude of this C-terminal-dependent effect is modulated by the n-terminal peptide 
sequence. This is the first demonstration that activity-dependent alternative promoter usage 
can change the function of a synaptic protein at excitatory synapses. Furthermore, the direction 
and degree of synaptic modulation exerted by different protein isoforms from a single gene 
locus is dependent on the combination of differential promoter usage and alternative splicing. 
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The ability of neurons to dynamically regulate their response to changing inputs is essential for the accurate assembly and mature function of the nervous system. The induction and 
expression of neuronal plasticity is mediated by numerous mecha-
nisms, many of which ultimately result in a change in the expression 
of synaptic proteins. For example, activity-dependent and develop-
mental stage-dependent transcription factors1 can use alternative 
promoters to create diversification of transcriptional regulation 
from a single locus2. Furthermore, functionally distinct proteins 
may be produced via regulated alternative splicing of messenger 
RNA3. Regulated protein trafficking then provides a mechanism 
to control the function of translated proteins. Many of the proteins 
that regulate neuronal plasticity are located in the postsynaptic 
density (PSD)4.
SynGAP (Synaptic GTPase-Activating Protein) is a key PSD sig-
nalling enzyme that negatively regulates small G protein signalling 
downstream of glutamate receptor activation. SynGAP is physically 
linked to postsynaptic scaffold proteins (PSD-95, SAP-102) that 
bind to the N-methyl-d-aspartate receptor (NMDAR) forming a 
signalling complex with Ras family proteins and their effectors5,6. 
In mice, SynGAP has been shown to direct NMDAR-dependent 
alterations in synapse density, dendritic spine shape and synaptic 
physiology6–8. These outcomes are thought to be due largely to 
altered AMPA (α-amino-3-hydroxy-5-methyl-4-isoxazole propi-
onic acid) receptor trafficking, which SynGAP both positively and 
negatively regulates6,8,9. Mice with reduced SynGAP expression 
show a decrease in hippocampal LTP and impaired spatial learn-
ing6,10. In humans, de novo mutations of SYNGAP have been iden-
tified in cases of non-syndromic mental retardation and autism 
spectrum disorder11,12.
Syngap is a complex gene that gives rise to multiple protein iso-
forms with numerous functional domains13 (Fig. 1a). Each isoform 
contains a central GAP domain that is responsible for enhancing 
the intrinsic GTPase activity of the small G proteins Ras and Rap. 
Three distinct isoforms of SynGAP, differing in their N-termini, 
have been reported although nothing is known about their origin 
or functional relevance8,14. SynGAPs A and B contain unique pep-
tide sequences and a complete pleckstrin homology (PH) domain 
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Figure 1 | Alternative SynGAP N-terminal peptides arise from distinct transcription starts sites. (a) A schematic diagram of potential synGAP 
isoforms, which vary at both n-terminus (A, B and C) and C-terminus (α1 and α2 studied here, are shown; β and γ are not shown). (b) The exonic 
structure (blocks) of the three Syngap 5′ variants A, B and C are illustrated on mouse genomic DnA (horizontal line, to scale in upper panel showing  
the full gene, scale is approximate in the expanded lower panel). Clusters of Tsss were found by RACE for Syngap A and C but only one Tss was found  
for Syngap B. The transcription start sites of Syngap A are clustered approximately 10 kb upstream from those of Syngap B and C. A thickening of the  
exon block indicates open reading frame that give rise to unique peptide sequences for synGAP A and B, and a truncated n terminus for synGAP C. 
Isoform-specific peptide sequences are shaded in c, the two alternative translation initiation codons (methionine, m) of Syngap A are highlighted by bold 
text, a horizontal line indicates the beginning of the pleckstrin homology (PH) domain.
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that may regulate lipid binding and protein–protein interactions15. 
SynGAP C is shorter, has no unique peptide sequence and lacks a 
complete pleckstrin homology domain.
SynGAP also shows variation in protein sequence at the 
C-terminus, which arises from alternative splicing of Syngap mRNA 
and mediates SynGAP’s interactions with other PSD proteins. The 
most studied C-terminal isoform is SynGAP α1, as it contains the 
PDZ-binding domain (QTRV) that mediates binding to scaffold-
ing proteins of the PSD6,7. However, alternative splicing of Syngap 
mRNA leads to multiple isoforms (SynGAP α2, β, γ) that lack this 
PDZ-binding domain13. In particular, SynGAP α2 results from 
alternative splice junction selection and the insertion of a single 
frame-shifting base pair that removes the PDZ-binding domain and 
adds 48 unique amino acids at the C-terminus.
The variability of SynGAP at both the N- and C-termini led 
us to hypothesize that the different isoforms have different func-
tions. The role of particular domains have been previously exam-
ined, however, these studies have not examined how the N- and 
C-termini combine to alter SynGAP function. Therefore, we sys-
tematically investigated the functional consequences of expressing 
different full-length isoforms on spontaneous synaptic transmis-
sion, as well as the origin and regulation of the N-terminal variable 
regions. Our results demonstrate that the direction and degree of 
modulation exerted by SynGAP on spontaneous synaptic transmis-
sion is regulated by the precise combination of differential promoter 
usage and alternative splicing.
Results
SynGAP N-terminal variation results from use of alternative 
promoters. Three different SynGAP N-terminal isoforms have been 
described that give rise to three distinct protein sequences, denoted 
SynGAP A–C13 (Fig. 1). We hypothesized that the expression of 
these N-terminal variants is under the control of different promoter 
regions and, hence, use unique sites for the initiation of transcription. 
We used 5′-rapid amplification of cDNA ends (5′ RACE) to clone 
full-length 5′ untranslated regions (UTRs) for each Syngap variant. 
Ten different clones were isolated by PCR using Syngap A-specific 
nested primers (Supplementary Table S1), representing ten 
different putative transcription start sites (TSSs; Supplementary 
Table S1). Four different clones contained an open reading frame 
encoding a protein with the starting amino-acid sequence MSYAP-, 
corresponding to the protein previously reported14, which we now 
refer to as SynGAP A1. A further seven different clones displayed 
a longer open reading frame predicted to encode a protein with 
an additional 14 amino acids (alternative methionines emboldened 
in Fig. 1c) at the N-terminus, which we now refer to as SynGAP 
A2. Nested primers specific for Syngap B yielded four clones of 
371 bp (Supplementary Table S1). These clones mapped to a single 
TSS ( + 10,515 bp, relative to ATG of Syngap A1). 5′ RACE with 
Syngap C-specific nested primers resulted in the isolation of eight 
different clones with 5′ UTRs ranging between 287 bp and 502 bp 
located between  + 11,164 bp and  + 11,379 bp (relative to ATG of 
Syngap A1, Supplementary Table S1). Thus, only Syngap B uses a 
single TSS. These data are in agreement with recent genome-wide 
findings that transcription initiation can arise through the use of 
a cluster of TSSs (as we have found for Syngaps A and C) and is 
more common than the use of a classical single TSS (Syngap B)16. 
Therefore, SynGAP N-terminal isoforms arise through the use of 
distinct TSSs with those for Syngaps B and C located over 10 kb 
downstream of the Syngap A.
To determine whether multiple promoters are present in the 
human gene, we performed a sequence comparison of the mouse 
genomic locus with that of human SYNGAP1 (Supplementary 
Fig. S1). Bioinformatic analysis indicates that all residues of the 
SynGAP N-terminal isoforms are conserved between mouse, rat 
and human, despite containing no predicted functional moieties. 
We identified several regions of high similarity in introns, as well 
as exons, indicating functional significance for intronic sequences 
in regulating promoter activity. Examining data from the ENCODE 
project (ENCyclopedia Of DNA Elements), which aims to identify 
functional elements in the human genome sequence, it is apparent 
that the regions of high homology are also enriched in molecular 
hallmarks (such as histone modifications) of promoter and regu-
latory elements (Supplementary Fig. S1). These enrichments occur 
in two clusters, one upstream of the Syngap A transcription start 
region and another upstream of the Syngap B and C start regions, 
suggesting that the different variants may be subject to independent 
transcriptional regulation.
SynGAP N-terminus is regulated by synaptic activity and age. To 
test whether Syngap is differentially regulated via different promoter 
regions, we examined the developmental and activity-dependent 
expression of Syngap variants in mouse cortical neurons using quan-
titative real-time reverse transcriptase (qRT)–PCR (Fig. 2). Network 
activity was increased in dissociated neuronal cultures by applying 
the GABAA receptor antagonist bicuculline (Bic; 50 µM) to dis-
inhibit synaptic activity. Syngap B and C were upregulated approxi-
mately twofold after 4 h of Bic treatment, whereas Syngap A was 
downregulated by 30% compared with vehicle-only control cultures 
(Fig. 2b). Total Syngap mRNA was unaltered indicating that Syngap 
A is the most abundant mRNA, as the decrease in Syngap A offsets 
the increase in Syngaps B and C. Application of the tetrodotoxin 
(TTX) blocked these changes in isoform expression, indicating 
that transcriptional regulation of Syngap is dependent on neuronal 
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Figure 2 | Activity- and development-dependent regulation of Syngap 
N-terminal variants. (a) Syngap 5′ variant mRnA levels were examined by 
RT–PCR analysis. (b) stimulation of synaptic activity in cultured forebrain 
neurons induces differential regulation of Syngap mRnA variants (isoform-
specific primers), despite causing no change in total Syngap levels (primers 
against the common core region). The approximate doubling of Syngap B 
and C is offset by the approximately 30% decrease in Syngap A. Cultures 
were stimulated at DIV 10–12 with bicuculine and 4-aminopyridine (4-AP) 
for 4 h, bicuculine/4-AP stimulation is labelled as ‘Bic’. Pairwise comparisons 
against control are indicated by asterisks over the bar. (c) RT–PCR analysis 
of mRnA levels in the developing postnatal mouse cortex reveals different 
temporal expression patterns of Syngap variants. statistics are one-way 
AnoVA, followed by post hoc Tukey tests. statistically significant pairwise 
comparisons are indicated by linked bars, Syngap A, AnoVA P < 0.05; post 
hoc tests P > 0.05, *P < 0.05, **P < 0.01. n=3–5. Error bars represent s.e.m.
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firing. No change was detected in Syngap levels after 1 h of treatment 
(data not shown).
Previous findings using antibodies that recognize all SynGAP 
isoforms indicated that SynGAP protein can be detected through-
out postnatal cortical development with adult levels being reached 
by postnatal day (P)1417. At the level of Syngap mRNA, primers 
that recognize all Syngap variants show that amounts peaked at the 
end of the second postnatal week and are significantly reduced by 
P21 (Fig. 2c, analysis of variance (ANOVA), P = 0.02, post hoc Tukey 
tests: P4 (92 ± 17%) versus P14 (243 ± 64%), P < 0.05; P14 versus P21 
(78 ± 11%), P < 0.05). However, each Syngap variant showed a distinct 
temporal profile of expression. Syngap A showed a pattern of regula-
tion (ANOVA, P < 0.05) but pairwise comparisons are not statistically 
significant by post hoc Tukey test, whereas Syngap B peaked at P14 
(ANOVA, P = 0.0013, P14 (254 ± 38%) compared with P4 (92 ± 8%), 
P7 (113 ± 17%), P21 (115 ± 13%), adult (100 ± 14%), all post hoc tests 
P =  < 0.01). In contrast, Syngap C mRNA was expressed at low levels 
up to P7 (12 ± 2%) but was subsequently upregulated approximately 
12-fold by P14 (139 ± 25%) and was not significantly downregulated 
in adulthood. Therefore, although Syngap B and C were similarly regu-
lated by Bic treatment, they show different developmental profiles sug-
gesting distinct (but possibly overlapping) mechanisms of regulation.
SynGAP N- and C- terminal combinations. The differential regu-
lation of SynGAP N-termini suggested that transcriptional regula-
tion could regulate SynGAP function. Previous work on SynGAP 
function had focused on one C-terminal isoform, SynGAP α1 (with 
a SynGAP C N-terminus), with very little known about the function 
of the α2 C-terminus. This leads to the obvious question of which 
combinations of N- and C-termini isoforms exist in neurons and if 
they can regulate synaptic function. Most Syngap sequences have 
been compiled from overlapping short clones, therefore, the in vivo 
linkage of N- and C-termini is not known. A full-length clone of 
SynGAP Cα1 has been isolated previously18 and during a screen of 
a mouse cDNA library we isolated a full-length clone for SynGAP 
Aα2 (Supplementary Information).
To determine if SynGAP α1 and α2 are present in neurons, we 
used isoform-specific antibodies to show that both C-terminal iso-
forms are expressed in the adult hippocampus and cortex (Fig. 3). 
Western blot analysis revealed a doublet for both SynGAP α1 and 
SynGAP α2 around 130 kDa but with the upper bands of α2 iso-
forms separating at a higher molecular weight (Fig. 3a), reflecting 
the longer peptide sequence at the C-terminus of SynGAP α2 rela-
tive to SynGAP α1. The presence of multiple bands further suggests 
that there is heterogeneity in the N- and C-terminal sequences that 
combine to generate a SynGAP protein. Mass spectrometric analy-
sis of purified PSDs confirmed that both SynGAP α1 and α2 are 
present at excitatory synapse indicating that α2 containing isoforms 
localize to PSDs despite lacking the QTRV sequence that binds to 
PDZ domains (Supplementary Table S2).
If there was absolute linkage between particular N- and 
C-termini one would expect that regulation of the C-termini 
would mirror that of specific N-termini. However, unlike what 
was observed for the N-terminal isoforms, stimulation of neuronal 
cultures with Bic for either 4 or 9 h did not lead to any change in 
SynGAP α1 and α2 protein levels (SynGAP protein levels were 
assayed instead of mRNA as SynGAP α1 and α2 mRNAs differ by 
only 1 bp), further supporting that multiple combinations of N- and 
C-termini exist (Fig. 3b,c).
These data indicate that multiple SynGAP proteins are generated 
from a single gene, suggesting that SynGAP may have several func-
tional roles at synapses.
Opposing effects of SynGAP isoforms on synaptic function. To 
test the hypothesis that promoter selection combined with alterna-
tive splicing to generate SynGAP isoforms with distinct effects on 
synaptic function, we transfected forebrain neurons with plasmids 
containing full-length cDNA clones of Syngap with all combinations 
of N-termini (A, B and C) and C-termini (α1 and α2) along with 
enhanced green fluorescent protein (eGFP). In these and all subse-
quent experiments where SynGAP A was used it was always Syn-
GAP A1 not A2 (see Fig. 1 and Supplementary Table S1). Whole-cell 
patch-clamp recordings from fluorescent neurons (Fig. 4) revealed 
heterogeneity in the proportion of cells that exhibited AMPA 
 receptor-mediated miniature excitatory synaptic currents (mEPSCs). 
We categorized neurons depending on whether mEPSCs were 
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Figure 3 | Expression of C-terminal isoforms SynGAP 1 and 2 are 
not regulated by synaptic activity. (a) mouse hippocampal homogenate 
was probed with antibodies against a region common to all isoforms 
(pan synGAP), synGAP α1 and synGAP α2. To allow direct comparison 
of electrophoretic migration between isoforms, a single-protein-bearing 
nitrocellulose lane was cut into strips and each strip incubated separately 
with antibodies, then re-assembled. Antibodies to synGAPα1 or synGAPα2 
each label doublets but of distinct molecular weight, consistent with the 
predicted difference in the length of their C-terminus. Furthermore, the 
distinct doublets suggest each C-terminus can be combined with several 
n-termini. (b,c) stimulation of synaptic activity in cultured forebrain 
neurons does not affect the expression level of different synGAP  
C-terminal isoforms. Cultures were stimulated at DIV 10–12 with bicuculine 
and 4-AP for 4 and 9 h, bicuculine/4-AP stimulation is labelled as ‘Bic’. 
Four experimental replicates were performed. Error bars represent s.e.m.
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present or not; neurons lacking any mEPSCs were termed ‘silent’ 
cells (Fig. 4b). Importantly, silent cells were viable and healthy as 
they were able to fire action potentials (in the absence of TTX) 
and did not differ from controls in their holding currents or gross 
morphology (data not shown). To assess whether the apparent 
silencing effect was due to the particular SynGAP construct trans-
fected, we examined the proportion of silent cells in each group 
(Fig. 4c). We found marked differences in the percentage of silent 
cells across all constructs (F(6, 37.4) = 3.96, P = 0.004). The majority 
(72.5%) of neurons transfected with SynGAP Aα1 lacked any 
mEPSCs, compared with a minority (10.5%) of control neurons. 
Only 45% of neurons expressing SynGAP Bα1 and 44.7% express-
ing Cα1 were silent. In contrast to the expression of SynGAP α1 
isoforms, the expression of SynGAP α2 isoforms did not increase 
the percentage of silent cells. The proportion of silent SynGAP Aα2- 
and SynGAP Cα2-expressing cells (14.3 and 5%) was comparable to 
control (10.5%). For SynGAP Bα2, none of the transfected neurons 
lacked mEPSCs. Comparison of the distribution of mEPSCs to the 
control quartiles (Fig. 4d) showed that SynGAP Aα2 follows the 
control distribution very closely with approximately 25% of values 
in each category. In contrast, the distributions of SynGAP Bα2 and 
Cα2 mEPSCs had a reduced proportion of events in the small (20% 
and 16%, respectively) and medium (19% and 20%, respectively) 
ranges and an increase in events in the largest category (36% and 
37%, respectively). Furthermore, the levels of silence observed in 
cells transfected with Syngap Aα1 and Aα2 are comparable between 
wild-type cells and in Syngap − / −  cells, indicating that the endo-
genous expression of a range of SynGAP isoforms does not impact 
on the data we have obtained that show isoform-specific effects on 
mEPSC amplitudes and frequencies (Fig. 4e).
To ensure that the differential effects of SynGAP isoform expres-
sion on synaptic function did not simply arise from a mislocaliza-
tion of particular isoforms, we transfected Syngap − / −  hippocampal 
neurons with each SynGAP isoform and performed immuno-
fluorescence with an antibody that recognizes all SynGAP isoforms. 
Figure 5 shows that all isoforms localize to dendrites and spines. 
Furthermore, there was no correlation between effect strength and 
isoform expression level (Supplementary Fig. S2), indicating that 
the overexpression of SynGAP isoforms per se does not alter syn-
aptic function in a non-specific manner. This is particularly high-
lighted by SynGAP Aα2, which had no effect on the proportion of 
silent cells or the profiles of the mEPSCs recorded, indicating that 
the effects of other isoforms are not due to non-specific effects of 
transfection or overexpression.
Heterogenous effect of SynGAP isoforms on mEPSC amplitudes. 
We next investigated the characteristics of functional synaptic 
activity in cells that exhibited detectable mEPSCs. Owing to the 
signal-to-noise ratio and finite duration of a recording, it is impossi-
ble to conclude that mEPSCs are completely absent from nominally 
‘silent’ cells. In other words, the data could be censored, both by the 
amplitude detection threshold (5 pA) and the duration of the initial 
analysis period (2 min in each case, corresponding to an event fre-
quency of 0.0083 Hz). Previous work has attempted to estimate the 
population amplitude and frequency by setting the values for ‘silent’ 
cells to their respective censorship bounds19. We have performed a 
similar analysis to that described by Milstein and Nicoll19 and this is 
shown in Supplementary Fig. S3. However, there are two drawbacks 
to this approach: first, it strongly biases the estimates of the popu-
lation means; second, it will lead to an underestimate of the vari-
ance and invalidate the interpretation of statistical tests. For these 
reasons, and owing to the observation that our non-silent cell data 
are distributed well away from the censorship bounds ( > 2 standard 
deviations for mEPSC amplitude and  > 5 standard deviations for 
log frequency, Supplementary Fig. S4), we decided not to include 
threshold values for silent cells in subsequent analyses.
To examine the amplitude and frequency of transfected cells 
in which mEPSCs were detected, we developed a statistical ana-
lysis that takes into account the potentially confounding effects 
of pooling data from different transfections and culture batches; 
specifically we used a generalized linear mixed model (GLMM) 
with transfection batch and culture batch as random effects 
(Supplementary Information).
In addition to introducing a silencing effect, the mean mEPSC 
amplitude (in those cells where such events were present) also 
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Figure 4 | Expression of different SynGAP isoforms alters the proportion 
of neurons exhibiting mEPSCs. (a) The effect of different synGAP 
isoforms on synaptic transmission was assessed by recording mEPsCs 
from neurons expressing one of six individual isoforms composed of an 
n-terminus of A, B or C linked to either an α1 or α2 C-terminus. (b,c) 
neurons were categorized as either having mEPsCs (top trace in b and 
grey bar in c; inset scale: 10 pA and 25 ms) or not (silent, lower trace in b 
and white bar in c). Data are displayed as a percentage of cells recorded 
for each construct. The percentage of neurons categorized as silent is as 
follows: control = 10.5%, n = 76; synGAP Aα1 = 72.6%, n = 62; synGAP 
Bα1 = 45%, n = 63; synGAP Cα1 = 44.7%, n = 40; synGAP Aα2 = 14.3%, 
n = 31; synGAP Bα2 = 0%, n = 38; and synGAP Cα-2 = 5%, n = 20. Data are 
from 18 transfections from 15 cultures, analysed using a generalized linear 
mixed model (F(6, 37.4) = 3.96, P = 0.004). (d) Data from all transfected 
cells are plotted to illustrate the proportion of silent cells (white bars), and 
mEPsCs of particular amplitude ranges (shaded bars). To illustrate the 
distribution of events, those from non-silent cells were further subdivided 
into four amplitude ranges, which were defined by the quartiles of the 
control event distribution. number of events (n) from number of cells 
(N); eGFP, n = 7,731, N = 27; synGAP Aα1, n = 2756, N = 11; synGAP Bα1, 
n = 2,664, N = 10; synGAP Cα1, n = 4,044, N = 17; synGAP Aα2, n = 6,712, 
N = 23; synGAP Bα2 n = 6,824, N = 21; synGAP Cα2, n = 4383, N = 15. 
Data are from 18 transfections from 15 separate cultures. (e) synGAP − / −  
forebrain neurons were transfected with synGAP Aα1 or Aα2. neurons 
were categorized as being silent (white bars) or having mEPsCs (shaded 
bars). Data are displayed as a percentage of cells recorded for each 
construct. The percentage of neurons categorized as silent is as follows: 
GFP only = 17%, n = 29; synGAP Aα1 = 69%, n = 29, P < 0.0001; synGAP 
Aα2 = 0%, n = 12. Population χ2 test, P < 0.0001. Error bars represent s.e.m.
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showed a dependency on the SynGAP isoform that was expressed 
(Fig. 6a). The mean mEPSC amplitude (Fig. 6b) of SynGAP 
Aα1-expressing neurons (15.6 pA) is decreased relative to con-
trol (22.3 pA). In addition, mean mEPSC amplitude was elevated 
in SynGAP Bα2- and Cα2-expressing neurons (26.9 and 27.8 pA, 
respectively, Fig. 6b) but not in SynGAP Aα2-expressing neurons 
(21.8 pA). Taken together, these results suggest that SynGAP α2 is 
capable of positively regulating synaptic strength, but this function 
is dependent on its N-terminal identity (F(6, 116) = 4.69, P < 0.001, 
linear mixed model (LMM)).
The differences between the distributions of mEPSCs ampli-
tudes are also illustrated if the quartiles of the control popula-
tion (as was shown in Fig. 4d) are plotted in the absence of silent 
neurons (Fig. 6c). The distributions of mEPSC amplitudes from 
SynGAP Aα1- and Bα1-expressing cells showed a larger propor-
tion of events within the smallest amplitude range of 5–12 pA 
(46% and 39%, respectively). Accordingly, the largest ampli-
tude range of  > 28 pA contained a smaller proportion of SynGAP 
Aα1 and Bα1 events (7% and 14%, respectively). The frequency 
distributions of mEPSC amplitudes for neurons transfected 
with all SynGAP isoforms, except SynGAP Aα2, were signifi-
cantly different from that of eGFP-transfected control neurons 
(Supplementary Fig. S5).
Heterogenous effect of SynGAP isoforms on mEPSC frequency. 
mEPSC frequency reflects the total number of functional synapses 
on a cell. We examined the mEPSC frequencies of non-silent cells 
by calculating the mean inter-event-interval for each cell. Consist-
ent with their effect on silencing and event amplitude, SynGAP iso-
forms were also found to influence mEPSC event frequency (Fig. 6d, 
F(6, 97) = 5.96, P < 0.001, LMM). Mean event frequencies for control 
cells were 2.1 Hz while SynGAP Aα1 showed a diminished event fre-
quency of 0.6 Hz. SynGAP Bα2-expressing cells exhibited an increase 
in mEPSC frequency (3.9 Hz) when compared with either eGFP-only 
or SynGAP Aα2-expressing neurons (2.1 and 1.6 Hz, respectively).
SynGAP Aα1 does not alter dendritic spine density, width or 
length. SynGAP Aα1 showed the greatest effect on neuronal silenc-
ing with 72.5% of transfected neurons showing no detectable mEP-
SCs. To determine whether this silencing resulted from an inability 
of these neurons to form postsynaptic specializations, we examined 
spine density and spine morphology in SynGAP Aα1-transfected 
cells compared with GFP-transfected cells. We found no difference 
in any parameter examined (Fig. 7), indicating that the silencing 
of hippocampal neurons by SynGAP Aα1 does not result from the 
loss or altered morphology of the postsynaptic apparatus despite the 
clear localization of this isoform to spines (see Fig. 5).
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Figure 5 | SynGAP isoforms localize to dendrites and dendritic spines. Different synGAP isoforms display different dendritic localization patterns but 
all are capable of reaching the postsynaptic compartment. synGAP − / −  forebrain neurons transfected with individual synGAP isoforms were probed 
with an antibody against all synGAP isoforms. Examples of dendritic sections from two different neurons are shown for each isoform. GFP (green) and 
synGAP labelling (red) are shown above the overlaid images. scale bar, 2 µm. Dendritic protein expression levels of various synGAP isoforms expressed 
in synGAP − / −  neurons were quantified by semi-quantitative confocal microscopy (supplementary Fig. s2).
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Discussion
Syngap is a complex gene that gives rise to numerous protein 
products. Little was known, however, about whether these dis-
tinct isoforms vary in expression profiles and/or function. Using 5′ 
RACE, we found that the variation in amino-acid sequence at the 
N-terminus of SynGAP (SynGAP A, B and C) arises from alterna-
tive promoter usage, with each 5′ variant showing a distinct profile 
of activity-dependent and developmental expressions. Further-
more, we show that SynGAP function is determined by the unique 
combination of N- and C-terminal domains. Previous work on Syn-
GAP focused exclusively on the α1 C-terminus and showed that 
its expression led to the weakening of synaptic strength. We dem-
onstrate that expression of a different C-terminus, α2, can lead to 
the opposing effect of synaptic strengthening. The magnitude of the 
effect in both cases was determined by the identity of the N-terminus 
of the protein: SynGAP Aα1 showed the largest synaptic weaken-
ing effect and SynGAPs Bα2 and Cα2 strengthened the synapse 
while Aα2 had no effect. These findings illustrate a novel mecha-
nism whereby alternative promoter usage and alternative splicing 
combine to regulate synaptic function (Fig. 8).
On stimulation of synaptic activity, we found no change in total 
Syngap mRNA, however, the relative abundance of the various 
N-terminal isoforms were altered. These findings suggest that all 
three N-terminal isoforms are under distinct, but possibly overlap-
ping, transcriptional control. As N-terminal isoform expression alters 
the synaptic function of SynGAP, synaptic activity not only controls 
synaptic function through transcriptional control of protein levels, 
but also by regulating the isoform expression through the use of 
alternative promoters. Activity-dependent regulation of alternative 
promoter usage has been reported for Bdnf, but unlike Syngap, this 
regulation does not alter the BDNF protein20. Although functional 
diversity of activity-regulated alternative splicing-derived isoforms 
is well established3,21, we know of no example where activity-regu-
lated alternative promoter usage gives rise to protein isoforms with 
different, let alone opposing, effects on synaptic function. Our data 
indicate that the functional consequences of changes in Syngap  
transcription can vary depending on the promoter being used and, 
hence, the isoform expressed. Little is known about the transcrip-
tion factors that regulate Syngap expression but examination of 
ENCODE data highlights two chromosomal regions that are likely 
to be involved. Future experiments will be necessary to deter-
mine the precise promoter elements and transcription factors that 
regulate the developmental and activity-dependent expression of 
particular SynGAP isoforms.
In addition to N-terminal variation, several C-terminal isoforms 
of SynGAP have been described. The most studied isoforms contain 
the α1 C-terminus, which contains the PDZ-binding motif (QTRV) 
responsible for SynGAP’s binding to scaffolding proteins such as 
PSD-95 and SAP-102. Rumbaugh et al.6 observed a 50% decrease 
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the quartiles of the control population of events. (d) Frequency of mEPsCs 
recorded from non-silent neurons transfected with different synGAP 
isoforms. Data were log transformed in order to make their distribution 
approximately Gaussian (methods) and are expressed relative to control 
thus representing log (fold change) of mEPsC frequency (F(6, 97) = 5.96, 
P < 0.001, Lmm,  ± s.e.m.). Absolute mEPsC frequencies (Hz ± sEm) are 
control = 2.07 ± 1.24, Aα1 = 0.6 ± 1.35, Aα2 = 1.55 ± 1.26, Bα1 = 1.65 ± 1.39, 
Bα2 = 3.94 ± 1.29, Cα1 = 2.32 ± 1.3 and Cα2 = 3.29 ± 1.32.
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Figure 7 | Dendritic spine density and morphology are not altered in SynGAP A1 transfected neurons. no significant differences are observed between 
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in mEPSC amplitude and an 85% decrease in mEPSC frequency 
in neurons overexpressing SynGAP Cα1; no alteration in synaptic 
function was seen if the last residue of the PDZ-binding domain 
(QTRV/E) was mutated. We also find that SynGAP α1 negatively 
regulates synaptic transmission, both increasing the proportion of 
silent cells and decreasing amplitude and frequency of remaining 
mEPSCs. We found that SynGAP Aα1 had the largest effects, silenc-
ing 72.5% of transfected neurons, whereas Bα1- and Cα1-containing 
isoforms approximately 45% of neurons.
In contrast, Syngap Bα2 and Cα2 led to an increase in syn-
aptic strength indicating that the direction of synaptic modula-
tion exerted by SynGAP is dependent on the isoform in question 
(Fig. 8). Our mass spectrometry analysis, locating both α1 and α2 
at synapses, also supports previous findings showing that SynGAP 
isoforms lacking a functional PDZ-binding domain localize to syn-
apses6, indicating that there are multiple microdomains with which 
SynGAP can associate to regulate synaptic function.
The ability of SynGAP α2 to increase mEPSC amplitude and 
 frequency is dependent on the N-terminal peptide sequence as 
SynGAP Bα2 increased both parameters, but SynGAP Aα2 did 
not alter synaptic function. Clearly, the knowledge of which iso-
forms, where and in what amounts is key to understanding the 
physiological role of SynGAP. However, similar to other exten-
sively spliced molecules, it is likely that all combinations of all 
N- and C-terminal combinations exist22. This study illustrates that 
the full peptide sequence of a protein, N- terminus to C-terminus, 
and combinations thereof, must be considered when examining its 
functional properties.
Our findings likely explain several discrepancies in the literature 
showing that SynGAP can act as both a negative and a positive regu-
lator of synaptic strength. For example, reduction of SynGAP expres-
sion has been seen to both increase7 and decrease9 the synaptic 
expression of AMPA receptors. This apparent contradiction could be 
explained by findings that SynGAP can be a RasGAP and negatively 
regulate the ERK/MAPK pathway to reduce the synaptic delivery of 
AMPA receptors, but can also be a RapGAP negatively regulating 
the p38/MAPK pathway to prevent the removal of synaptic AMPA 
receptors23. Crucially, regions outwith the GAP domain have been 
shown to be essential in allowing SynGAP, and other bifunctional 
GAPs, to work as RapGAPs (ref. 24 and references within). Further 
work is required to determine whether different SynGAP isoforms 
differ in their Ras/Rap specificity and whether this is a mechanism 
by which SynGAP exerts opposing effects on synaptic strength.
Alternatively, the reduction in mEPSC frequencies could result 
from changes in presynaptic release probability. Our low transfec-
tion efficiency means that a negligible percentage of inputs arise 
from other transfected neurons, making it unlikely that presynap-
tic expression of SynGAP causes the ‘silencing’. Furthermore, the 
normal density and morphology of dendritic spines suggests the 
‘silencing’ effect of SynGAP Aα1 is not the result of a large-scale 
loss of postsynaptic machinery. Alterations in presynaptic function 
could result from retrograde signalling between transfected (post-
synaptic) neurons and presynaptic release sites. Alternatively, recent 
studies have suggested that AMPA receptor populations activated 
by spontaneous (TTX-insensitive) and evoked (action potential 
dependent) release of glutamate may be distinct25. Therefore, iso-
forms of SynGAP may differentially regulate the distribution of 
glutamate receptors within the postsynaptic membrane. Irrespec-
tive of how SynGAP alters synaptic function, our findings indicate 
that the regulation of expression of a single gene, Syngap, through 
the combination of alternative promoter usage and splicing can 
markedly alter the function of the resulting protein.
Understanding the mechanisms by which synaptic plasticity is 
induced and expressed is key to our understanding of brain develop-
ment as well as adult learning and memory. We demonstrate that 
the expression of multiple protein isoforms from a single gene can 
have opposing effects on synaptic function. Although functional 
diversity among activity-dependent alternatively spliced isoforms is 
well established3, each SynGAP isoform has a unique effect on syn-
aptic function that is determined by the combination of the N- and 
C-termini that results from the use of multiple alternative promot-
ers and alternative splicing, respectively. This creates an exquisitely 
fine-tuned system that allows synaptic activity and developmental 
stage to alter protein isoform expression to control not only the 
magnitude, but also crucially the direction, of synaptic plasticity.
Methods
Molecular biology. 5′ RACE was performed on RNA isolated from p14 forebrain 
of C57Bl6 mice (FirstChoice RLM-RACE kit). Quantitative RT–PCR was per-
formed using RNA isolated from forebrain and stimulated neuronal culture lysates 
using primers complementary to Syngap variant-specific sequences and normalized 
to 18S rRNA or glyceraldehyde 3-phosphate dehydrogenase mRNA expression. 
Full-length SynGAP Aα2 was isolated from Superscript Mouse Brain plasmid 
cDNA library (10655025 in pCMV-sport6, Invitrogen) by colony hybridization 
using a 32P-dCTP-labelled DNA probe specific to a central region of SynGAP. The 
range of SynGAP clones used were then constructed from this clone, a separately 
isolated SynGAP α1 clone and 5′ regions of B and C, which were cloned by PCR 
amplification from forebrain cDNA, and subcloned without 3′ UTR into a cytome-
galovirus expression vector. Additional details, including construction specifics and 
primer sequences, are given in the Supplementary Information.
Identification of SynGAP isoforms by mass spectrometry. In order to validate 
the presence of SynGAP isoforms in the PSD, tandem mass spectrometry data ob-
tained from analysis of purified mouse PSD and PSD-95-associated complexes26,27 
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were analysed for the presence of isoform-specific sequences. Briefly, tandem mass 
spectrometry data were processed using Proteome Discoverer version 1.1 (Thermo 
Fisher Scientific) and the resultant peak lists were searched against a mouse IPI 
database (downloaded June 2007) supplemented with SynGAP isoform sequences 
using MASCOT v2.2 (Matrix science). Precursor ion tolerance was set to 10 p.
p.m. and fragment ion tolerance was set to 0.5 Da. Enzyme specificity was set to 
Trypsin with two missed cleavages. Carbamidomethyl modification of cysteine 
residues, oxidation of methionine, deamidation of asparagine and glutamine resi-
dues and acetyl (protein N-term) were set as variable modifications. The Mascot 
search results were then submitted to our in-house version of Mascot Percolator 
v1.1 to re-score peptide spectrum matches and to produce a final set of peptide 
identifications with a 1% (peptide level) false discovery rate. Tandem mass spectra 
that identified SynGAP isoform-specific sequences (Supplementary Data 1) were 
manually inspected. See Supplementary Table S2 for representative spectra and 
Supplementary Methods for a link to the appropriate database.
Neuronal cultures. Mouse forebrain cultures were derived from E17.5 embryos 
and maintained in Neurobasal, B-27, Glutamax, Pen/Strep (Invitrogen). Cultured 
neurons (days in vitro (DIV) 10–12) were stimulated with Bic (50 µM) and 4-AP 
(250 µM) to induce an increase in the frequency of action potential-evoked  
synaptic currents28.
Biochemistry. For comparison of SynGAP isoform molecular weights, mouse  
P14 brain lysates were electrophoresed in a single large well, transferred to  
nitrocellulose, cut into strips and probed with isoform-specific SynGAP antibodies; 
pan (Cambridge Biosciences, PA-046, 1:4,000), α1 (Millipore, 06-900, 1:4,000), 
α2 (Abcam, EPR2883Y, 1:4,000). Quantification was performed by densitometry 
(ImageJ) and normalized against Neurofilament M (Abcam, Cambridge, MA, USA, 
1:6,000), similar results we obtained by normalization against β-actin (Abcam, 
1:10,000). Standard western blotting was completed as previously described17.
Electrophysiology. Whole-cell patch-clamp recordings were performed on DIV 9–11 
fluorescent neurons between 16 and 36 h after liposome-mediated co-transfection with 
eGFP and SynGAP. External recording solution contained (in mM) NaCl (150), KCl 
(3), HEPES (10), Glucose (10), CaCl2 (2.5), MgCl2 (1.3), pH 7.3. Internal solution 
contained (in mM) K-gluconate (130), KCl (10), HEPES (10), EGTA (0.1), glucose 
(10), Na-phosphocreatine (10), Mg-ATP (4), Mg-GTP (0.5), pH 7.3. mEPSCs were 
recorded at a holding potential of  − 70 mV in the presence of TTX (500 nM) and 
picrotoxin (50 µM). Access resistance (Ra) was monitored following membrane rup-
ture and dialysis, and recordings were abandoned if Ra  > 28 MΩ. Recordings with an 
unstable or  >  − 150 pA holding current or high noise (greater than 4 pA root mean 
square (RMS)) were excluded. For mEPSC analysis, at least 6 min of spontaneous 
activity was recorded from each cell, with access resistance measured every 2 min. 
An event amplitude threshold was set at 5 pA above the baseline, at least 300 events 
were analysed per cell. A minimum recording length of 2 min, where no mEPSCs 
were apparent, was required for a cell to be classified as silent. No minimum record-
ing length was necessary to designate a cell as non-silent, the appearance of obvious 
mEPSCs was sufficient. Cells with high RMS noise but with mEPSCs obvious above 
the noise were not included in this analysis.
Statistical analysis. mEPSC amplitude and frequency data from the SynGAP 
overexpression experiments (Fig. 4) were analysed by fitting a LMM using residual 
maximum likelihood in GenStat v13 (VSN International). Data fitted in the model 
represented mean event amplitudes and (log) event frequencies for individual 
cells (123 ‘non-silent’ cells, 15 culture batches and 18 transfections). Culture batch 
(representing cells from the same tissue) and Transfection (representing repeat 
transfections) were included in the model as random effects, with no interaction 
term; the fixed effect was the Expression Construct (levels = GFP, SynGAP Aα1 and 
so on). Residuals were examined to check for the appropriateness of the normality 
assumption and revealed a satisfactory fit (Supplementary Fig. S6).
The proportions of silent cells observed were analysed similarly (Fig. 4), using a 
GLMM with a binomial data model (allowing for under/overdispersion) and a logit 
link function (218 cells, 15 culture batches and 18 transfections). Again, Expression 
Construct was included as a fixed effect, whereas Culture batch and Transfection 
were included as random effects, with no interaction term. F-statistics represent 
Wald tests between the full model and a model in which the fixed effect is dropped.
Model output is included for both LMMs and the GLMM in the Supplementary  
Information. Informations on other statistical tests used are found within the 
relevant figure legends. 
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